Allergen Immunotherapy (AIT): a prototype of Precision Medicine
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Precision medicine is a medical model aiming to deliver customised healthcare - with medical decisions, practices, and/or products tailored to the individual patient informed but not directed by guidelines. Allergen immunotherapy has unique immunological rationale, since the approach is tailored to the specific IgE spectrum of an individual and modifies the natural course of the disease as it has a persistent efficacy after completion of treatment. In this perspective Allergen Immunotherapy - AIT has to be presently considered a prototype of Precision Medicine. Precise information and biomarkers provided by systems medicine and network medicine will address the discovery of Allergen immunotherapy biomarkers for (i) identification of the causes, (ii) stratification of eligible patients for AIT and (iii) the assessment of AIT efficacy. This area of medical technology is evolving rapidly and, compelemented by e-health, will change the way we practice medicine. It will help to monitor patients' disease control and data for (i) patient stratification, (ii) clinical trials, (iii) monitoring the efficacy and safety of targeted therapies which are critical for reaching an appropriate reimbursement. Biomarkers associated with e-health combined with a clinical decision support system (CDSS) will change the scope of Allergen immunotherapy. The cost/effectiveness of Allergen immunotherapy is a key issue for successful implementation. It should include the long-term benefits in the pharmaco-economic evaluation, since no other allergy treatment has this specific characteristic. AIT is the prototype of current and future precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 1×
“Precise information and biomarkers provided by systems medicine [32] and network medicine [66] will address the discovery of AIT biomarkers for (i) precise identification of aetiology, which leads to (ii) stratification of patients eligible for AIT ( i.”
BackgroundA CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195 · cited 1×
“One of the recent examples is cystic fibrosis: the detection of the causative molecular mechanism of the disease in 4 % of the patients permitted a specific intervention which led to a complete reversion of the disorder [4].”
BackgroundThe Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Genomewide Association Studies and Assessment of the Risk of Disease
Manolio, T. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905980 · Cited by 1,512
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.053 · Cited by 623
Self-citationA WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
Canonica, G. W., Ansotegui, I. J., Pawankar, R., Schmid-Grendelmeier, P., van Hage, M., Baena-Cagnani, C. E., Melioli, G., Nunes, C., Passalacqua, G., Rosenwasser, L., et al. (2013) · World Allergy Organization Journal · doi:10.1186/1939-4551-6-17 · Cited by 432
Self-citationWalker, S., Khan-Wasti, S., Fletcher, M., Cullinan, P., Harris, J., & Sheikh, A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.034 · Cited by 431
Quality of Life in Allergic Rhinitis and Asthma
LEYNAERT, B., NEUKIRCH, C., LIARD, R., BOUSQUET, J., & NEUKIRCH, F. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912033 · Cited by 407 · cited 1×
“Impairment of quality of life with allergic rhinitis is greater than that caused by asthma [68].”
BackgroundSelf-citationPinart, M., Benet, M., Annesi-Maesano, I., von Berg, A., Berdel, D., Carlsen, K. C. L., Carlsen, K.-H., Bindslev-Jensen, C., Eller, E., Fantini, M. P., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70277-7 · Cited by 334
Self-citation
Cited by
A WAO—ARIA—GA2LEN Consensus Document on Molecular-Based Allergy Diagnosis (PAMD@): Update 2020
Ansotegui, I. J., Melioli, G., Canonica, G. W., Gómez, R. M., Jensen-Jarolim, E., Ebisawa, M., Luengo, O., Caraballo, L., Passalacqua, G., Poulsen, L. K., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100091 · Cited by 122
Self-citationPollen Allergens for Molecular Diagnosis
Pablos, I., Wildner, S., Asam, C., Wallner, M., & Gadermaier, G. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0603-z · Cited by 71
Molecular Allergology and Its Impact in Specific Allergy Diagnosis and Therapy
Barber, D., Diaz‐Perales, A., Escribese, M. M., Kleine‐Tebbe, J., Matricardi, P. M., Ollert, M., Santos, A. F., & Sastre, J. (2021) · Allergy · doi:10.1111/all.14969 · Cited by 59
Metadata
- Authors
- Canonica, G., Bachert, C., Hellings, P., Ryan, D., Valovirta, E., Wickman, M., De Beaumont, O., & Bousquet, J.
- Venue
- World Allergy Organization Journal
- Publisher
- Elsevier BV
- Published
- 2015
- Volume
- 8
- Issue
- 1
- Pages
- 31
- ISSN
- 1939-4551 (ISSN-L)
- OpenAlex
- W2170067842
- Cited by
- 114
- References
- 13
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allergen Immunotherapy (AIT): a prototype of Precision Medicine. https://app.cochat.ai/papers/10.1186/s40413-015-0079-7
- The paper
- Canonica, G., Bachert, C., Hellings, P., Ryan, D., Valovirta, E., Wickman, M., De Beaumont, O., & Bousquet, J. (2015). Allergen Immunotherapy (AIT): a prototype of Precision Medicine. World Allergy Organization Journal. https://doi.org/10.1186/s40413-015-0079-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.